Operating Company Healthcare

Advarra

Columbia, Maryland, United States

Advarra provides a platform and trusted oversight for clinical trials, including independent IRB and global research compliance services, plus integrated research technology solutions used by sponsors and CROs worldwide.

Focus Areas
Institutional Review Board (IRB) Services, Institutional Biosafety Committee (IBC) Services, Research compliance consulting
Website
www.advarra.com

Tracked deals

7

7 tracked deals across 2019-2021.

Recent pace

0

0 tracked deals announced in the last 12 months.

Deal mix

Buyout

6 buyout · 1 addon

Advarra Acquisition Volume by Year

Last 3 years

Acquisition volume by year Annual acquisition counts for the last 3 years for Advarra. 2 2019 2 2020 3 2021

Supporting Data

Recent Transactions

  • Advarra Acquires Watermark Research Partners
    July 20, 2021
    Buyer
    Advarra
    Target
    Watermark Research Partners, Inc.
    Industry
    Healthcare Services
    Location
    Indiana, United States
    Type
    Buyout

    Advarra has acquired Watermark Research Partners, a specialist provider of independent data safety monitoring board (DSMB), data monitoring committee (DMC) and endpoint adjudication committee (EAC) services. The deal adds biostatistics, protocol endpoint design, and data safety monitoring capabilities to Advarra's integrated IRB/IBC and research oversight offerings and expands its global research oversight footprint.

  • Advarra Acquires Bio-Optronics from Mainsail Partners
    March 9, 2021
    Buyer
    Advarra
    Target
    Bio-Optronics
    Seller
    Mainsail Partners
    Industry
    Software
    Location
    New York, United States
    Type
    Buyout

    Advarra has acquired Bio-Optronics, the maker of the CCTrialSuite clinical trial management system (CTMS), from growth equity firm Mainsail Partners. The acquisition expands Advarra's site-focused technology portfolio, broadens its coverage of site networks and health systems, and enhances capabilities for connecting sponsors, CROs and research sites.

  • Advarra Acquires YourEncore
    January 7, 2021
    Buyer
    Advarra
    Target
    YourEncore
    Industry
    Healthcare Services
    Location
    Indiana, United States
    Type
    Buyout

    Advarra has acquired YourEncore, a provider of drug development and commercialization advisory and consulting services. The acquisition expands Advarra's consulting capabilities—combining YourEncore's centers of excellence in quality, regulatory, and clinical with Advarra's IRB, IBC review and clinical site technology offerings to better serve biopharmaceutical sponsors, device manufacturers and academic medical centers.

  • Advarra Acquires IntegReview IRB
    November 9, 2020
    Buyer
    Advarra
    Target
    IntegReview IRB
    Industry
    Healthcare Services
    Location
    Texas, United States
    Type
    Buyout

    Advarra has acquired IntegReview IRB, an AAHRPP-accredited central IRB based in Austin, Texas. The acquisition expands Advarra's IRB and early-phase clinical research capabilities, establishes its first office in the southern U.S., and will be integrated into Advarra over approximately six months.

  • Advarra Acquires IRB Company, Inc. (IRBco)
    April 20, 2020
    Buyer
    Advarra
    Target
    IRB Company, Inc. (IRBco)
    Industry
    Healthcare Services
    Location
    California, United States
    Type
    Buyout

    Advarra, a leading provider of IRB, IBC, research technology and compliance services, has acquired IRB Company, Inc. (IRBco), an AAHRPP-accredited central IRB that has conducted research reviews in the U.S. since 1981. The acquisition expands Advarra’s integrated IRB capabilities and institutional reach across the clinical research ecosystem.

  • Advarra Acquires Forte
    September 5, 2019
    Buyer
    Advarra
    Target
    Forte
    Seller
    Primus Capital
    Industry
    Software
    Location
    Wisconsin, United States
    Type
    Buyout

    Advarra, a leading provider of IRB and research compliance services, announced its intent to acquire Forte, a market-leading provider of clinical research technology including the OnCore CTMS. The deal (Forte sold by Primus Capital) expands Advarra's site-centric technology and eClinical capabilities to better serve academic medical centers, cancer centers, and health systems.

  • Advarra Acquires Quorum Review IRB and Kinetiq Research and Technology Consulting
    March 5, 2019
    Buyer
    Advarra
    Target
    Quorum Review IRB, Kinetiq Research and Technology Consulting
    Industry
    Healthcare Services
    Location
    Washington, United States
    Type
    Addon

    Advarra acquired Quorum Review IRB and its research and technology consulting division, Kinetiq, expanding the combined company's IRB, IBC and research compliance capabilities. The deal creates the largest global integrated IRB and research compliance services organization, broadening Advarra’s geographic reach (including Quorum’s Seattle office) and service offerings for pharmaceutical, biotech, device, academic and health system clients.

Related Acquisition Pages

Healthcare Services Buyers & Acquisitions 5 tracked deals by Advarra. Software Buyers & Acquisitions 2 tracked deals by Advarra. Acquisitions in Indiana 2 tracked deals by Advarra. Acquisitions in California 1 tracked deal by Advarra. Acquisitions in New York 1 tracked deal by Advarra. Acquisitions in Texas 1 tracked deal by Advarra.

Related articles

Selling a company? Get in front of buyers like Advarra

Turn tracked acquisition activity into an outreach-ready buyer list.

Find buyers like these →